Lintao Cai

机构：Chinese Academy of Sciences, Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine, Institute for Biomedicine, Shenzhen Institutes of Advanced Technology, University of Chinese Academy of Sciences · ORCID：0000-0002-2461-6390

发表论文 317 篇 · 总被引 19341 次 · h-index 75

代表论文

• Chemically engineered antibodies for autophagy-based receptor degradation (2025 · Nature Chemical Biology · 被引 26)
• Nanobiohybrid Oncolytic Bacteria with Optimized Intratumoral Distribution for Combined Sono–Photodynamic/Immunotherapy (2025 · ACS Nano · 被引 17)
• Programmable ultrasound-mediated swarms manipulation of bacteria–red blood cell microrobots for tumor-specific thrombosis and robust photothermal therapy (2024 · Trends in biotechnology · 被引 16)
• Bioorthogonal oncolytic-virus nanovesicles combined bio-immunotherapy with CAR-T cells for solid tumors (2024 · Biomaterials Science · 被引 14)
• Berberine-doped montmorillonite nanosheet for photoenhanced antibacterial therapy and wound healing (2024 · Journal of Colloid and Interface Science · 被引 11)
• Precision Photothermal Therapy at Mild Temperature: NIR‐II Imaging‐Guided, H 2 O 2 ‐Responsive Stealth Nanobomb (2024 · Advanced Healthcare Materials · 被引 9)